RecruitingNCT00807482

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease

Diagnostic and Clinical Characterization of Patients With Unusual Genetic Disorders of the Airways


Sponsor

University of North Carolina, Chapel Hill

Enrollment

1,800 participants

Start Date

Jan 1, 2004

Study Type

OBSERVATIONAL

Conditions

Summary

The overall short-term goals of this project include the following: 1) identify the genes that are key to the function of respiratory cilia to protect the normal lung; and 2) the effects of genetic mutations that adversely affect ciliary function and cause primary ciliary dyskinesia (PCD), which results in life-shortening lung disease. The long-term goal of this project is to develop better understanding of the underlying genetic variability that adversely modifies ciliary function, and predisposes to common airway diseases, such as asthma and chronic obstructive pulmonary disease.


Eligibility

Inclusion Criteria2

  • Patients who have a high suspicion for the diagnosis of PCD, based on clinical features
  • Healthy Volunteers who have a family member with confirmed PCD.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00807482


Related Trials